In Vitro Toxicological Profile of Labetalol-Folic Acid/Folate Co-Administration in H9c2(2-1) and HepaRG Cells
<i>Background and Objectives:</i> The consumption of dietary supplements has increased over the last decades among pregnant women, becoming an efficient resource of micronutrients able to satisfy their nutritional needs during pregnancy. Furthermore, gestational drug administration might...
Main Authors: | Robert Rednic, Iasmina Marcovici, Razvan Dragoi, Iulia Pinzaru, Cristina Adriana Dehelean, Mirela Tomescu, Diana Aurora Arnautu, Marius Craina, Adrian Gluhovschi, Mihaela Valcovici, Aniko Manea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/6/784 |
Similar Items
-
The Effect of Labetalol or Remifentanil on Blood Pressure and Heart Rate after Laryngoscopy and Intubation
by: Azim Honarmand, et al.
Published: (2017-02-01) -
Labetalol versus Methyldopa for Treatment of Pregnancy Induced Hypertension
by: Maria Arshad, et al.
Published: (2024-08-01) -
Comparative study of efficacy of methyldopa vs labetalol in the management of pregnancy induced hypertension in respect to maternal and perinatal outcomes
by: Bidisha Roychoudhury, et al.
Published: (2024-05-01) -
Effectiveness and safety of intravenous labetalol in severe pre-eclampsia and eclampsia at a teaching institution in Chhattisgarh
by: Rachna Jain, et al.
Published: (2024-09-01) -
Comparative Study of Heart Rate and Blood Pressure Changes during and after Electroconvulsive Therapy Followed by Two Different Doses of Labetalol
by: Behzad Nazemroaya, et al.
Published: (2019-10-01)